Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications

Cited by (1,003)

Items 401–500 of 1,003

  1. Dual TGF‐β and PD‐1 blockade synergistically enhances MAGE‐A3‐specific CD8+ T cell response in esophageal squamous cell carcinoma
    Xinfeng Chen, Liping Wang, Pupu Li, Mengjia Song, Guohui Qin, Qun Gao, Zhen Zhang, Dongli Yue, Dan Wang, Shufeng Nan et al. · 2018 · International Journal of Cancer
  2. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
    Regina Jitschin, Domenica Saul, Martina Braun, Şehmus Tohumeken, Simon Völkl, Roman Kischel, Michael Lutteropp, Cédric Dos Santos, Andréas Mackensen, Dimitrios Mougiakakos · 2018 · Journal for ImmunoTherapy of Cancer
  3. Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
    Anita Thyagarajan‐Sahu, Mamdouh Salman A. Alshehri, Kelly L. Miller, Catherine M.T. Sherwin, Jeffrey Bryant Travers, Ravi P. Sahu · 2019 · Cancers
  4. Glioblastomas exploit truncated O - linked glycans for local and distant immune modulation via the macrophage galactose-type lectin
    Sophie A. Dusoswa, Jan Verhoeff, Erik R. Abels, Santiago P. Méndez‐Huergo, Diego Omar Croci, Lisan H Kuijper, Elena de Miguel, Valérie M Wouters, Myron G. Best, Ernesto Rodríguez et al. · 2020 · Proceedings of the National Academy of Sciences
  5. Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression
    Naofumi Mukaida, Soichiro Sasaki, Tomohisa Baba · 2020 · International Journal of Molecular Sciences
  6. Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells
    Charles Maisonneuve, Derek K.L. Tsang, Elisabeth G. Foerster, Lukian Maxence Robert, Tapas Mukherjee, David Prescott, Ivan Tattoli, Paul Lemire, Daniel A. Winer, Shawn Winer et al. · 2021 · Cell Reports
  7. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
    Pat Gulhati, Aislyn P. Schalck, Shan Jiang, Xiaoying Shang, Chang‐Jiun Wu, Pingping Hou, Sharia Hernández Ruiz, Luisa M. Solis Soto, Edwin Roger Parra, Haoqiang Ying et al. · 2022 · Nature Cancer
  8. Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond
    Mirta Mosca, Maria Concetta Nigro, Rachele Pagani, Andrea De Giglio, Alessandro Di Federico · 2023 · Biomolecules
  9. CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma
    Viktor Umansky, C Blattner, Christoffer Gebhardt, Jochen Sven Utikal · 2017 · Cancer Immunology Immunotherapy
  10. Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment
    Alba Gonzàlez-Juncà, Kyla E. Driscoll, Ilenia Pellicciotta, Shisuo Du, Chen Hao Lo, Ritu Roy, Renate Parry, Iliana Tenvooren, Diana M. Marquez, Matthew H. Spitzer et al. · 2018 · Cancer Immunology Research
  11. The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia
    Débora Bifano Pimenta, Vanessa Araújo Varela, Tarcila Santos Datoguia, Victória Bulcão Caraciolo, Gabriel Herculano Lopes, Welbert Oliveira Pereira · 2021 · Frontiers in Cell and Developmental Biology
  12. AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes
    Wurood Hantoosh Neamah, Narendra Prasad Singh, Hasan Alghetaa, Osama Azeldeen Abdulla, Saurabh Chatterjee, Philip Brandon Busbee, Mitzi Nagarkatti, Prakash S. Nagarkatti · 2019 · The Journal of Immunology
  13. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
    Rebekka Bitsch, Annina Kurzay, Feyza Gül Özbay Kurt, Carolina De La Torre, Samantha Lasser, Alisa Lepper, Alina Siebenmorgen, Verena Alexandra Müller, Peter Altevogt, Jochen Sven Utikal et al. · 2022 · Journal for ImmunoTherapy of Cancer
  14. Myeloid-Derived Suppressor Cells and Radiotherapy
    Carlos Jiménez‐Cortegana, Claudia Galassi, Vanessa Klapp, Dmitry I. Gabrilovich, Lorenzo Galluzzi · 2022 · Cancer Immunology Research
  15. Macrophage function in the elderly and impact on injury repair and cancer
    Lelinh Duong, Hannah G. Radley‐Crabb, Bo Ryung Lee, Danielle E. Dye, Fiona J. Pixley, Miranda D. Grounds, Delia Jane Nelson, Connie Jackaman · 2021 · Immunity & Ageing
  16. Dysregulated Immunity and Immunotherapy after Sepsis
    Dijoia B. Darden, Lauren S. Kelly, Brittany P. Fenner, Lyle L. Moldawer, Alicia M. Mohr, Philip Alexander Efron · 2021 · Journal of Clinical Medicine
  17. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
    Shi-Yong Neo, Le Tong, Joni Chong, Yaxuan Liu, Xu Jing, Mariana M. S. Oliveira, Yi Chen, Zi-Qing Chen, Keene Lee, N. Burduli et al. · 2024 · Science Translational Medicine
  18. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
    Hanna Grauers Wiktorin, Malin S. Nilsson, Roberta Kiffin, Frida Ewald Sander, Brianna C. Lenox, Anna Rydström, Kristoffer Hellstrand, Anna Martner · 2018 · Cancer Immunology Immunotherapy
  19. Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer
    Qingfei Wang, Ian H. Guldner, Samantha M. Golomb, Longhua Sun, Jack A. Harris, Xin Lü, Siyuan Zhang · 2019 · Nature Communications
  20. Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice
    Yufeng Liu, Michela Perego, Qiang Xiao, Yumei He, Shuyu Fu, Juan He, Wangkai Liu, Xing Li, Yan‐Lai Tang, Xiaoyu Li et al. · 2019 · Journal of Clinical Investigation
  21. Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers
    Hui Xuan Lim, Tae Sung Kim, Chit Laa Poh · 2020 · International Journal of Molecular Sciences
  22. Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
    Elisa Peranzoni, Vincenzo Ingangi, Elena Masetto, Laura Pinton, Ilaria Marigo · 2020 · Frontiers in Immunology
  23. Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors
    Alexander Helm, Walter Tinganelli, Palma Simoniello, Fuki Kurosawa, Claudia Fournier, Takashi Shimokawa, Marco Durante · 2020 · International Journal of Radiation Oncology*Biology*Physics
  24. Immunotherapy of gastric cancer: Past, future perspective and challenges
    Jun Xie, Liping Fu, Jin Li · 2020 · Pathology - Research and Practice
  25. Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
    Lorenzo Lindo, Lauren Wilkinson, Kevin Anthony Hay · 2021 · Frontiers in Immunology
  26. Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
    Maria Kotsari, Vassiliki Dimopoulou, John S. Koskinas, Athanasios Armakolas · 2023 · International Journal of Molecular Sciences
  27. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence
    Salminen, Antero, Kauppinen, Anu, Kaarniranta, Kai · 2018 · Biogerontology
  28. Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
    Elizabeth Anne Comen, Robert L. Bowman, Maria Kleppe · 2018 · Frontiers in Cell and Developmental Biology
  29. Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer
    Elham Safarzadeh, Shahryar Hashemzadeh, Pascal H. G. Duijf, Behzad Mansoori, Vahid Khaze, Ali Mohammadi, Tohid Kazemi, Mehdi Yousefi, Milad Asadi, Hamed Mohammadi et al. · 2018 · Journal of Cellular Physiology
  30. PI3Kγ activates integrin α4 promotes immune suppressive myeloid cell polarization during tumor progression
    P. Foubert, Megan M. Kaneda, J. Varner · 2017 · Cancer immunology research
  31. Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?
    Chiara Focaccetti, Valerio Izzi, Monica Benvenuto, Sara Fazi, Sara Ciuffa, Maria Gabriella Giganti, Vito Potenza, Vittorio Manzari, Andrea Modesti, Roberto Bei · 2019 · International Journal of Molecular Sciences
  32. Photodynamic Therapy and Immune Checkpoint Blockade†
    Gwendolyn M. Cramer, Edmund K. Moon, Keith A. Cengel, Theresa M. Busch · 2020 · Photochemistry and Photobiology
  33. Low-Density Neutrophils in Healthy Individuals Display a Mature Primed Phenotype
    Carlos Blanco-Camarillo, Omar Rafael Alemán, Carlos Rosales · 2021 · Frontiers in Immunology
  34. New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway
    Sheng‐Kai Hsu, Kai‐Chun Cheng, Miracle Oluebube Mgbeahuruike, Yi‐Hsiung Lin, Chang‐Yi Wu, Huimin Wang, Chia‐Hung Yen, Chien‐Chih Chiu, Shwu‐Jiuan Sheu · 2021 · International Journal of Molecular Sciences
  35. A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples
    Yanan Tang, Turun Song, Lu Gao, Saifu Yin, Ming Ma, Yun Tan, Lijuan Wu, Yang Yang, Yanqun Wang, Tao Lin et al. · 2022 · Nature Communications
  36. Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance
    Rosa A. Sierra, Jimena Trillo-Tinoco, Eslam T. Mohamed, Lolie C. Yu, Bhagelu R. Achyut, Ali S. Arbab, Jennifer W. Bradford, Barbara A. Osborne, Lucio Miele, Paulo C. Rodrı́guez · 2017 · Cancer Research
  37. Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    Lina Wirestam, Sabine Arve-Butler, Petrus Linge, Anders A Bengtsson · 2019 · Frontiers in Immunology
  38. Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
    Nicola Tumino, Anna Laura Di Pace, Francesca Besi, Linda Quatrini, Paola Vacca, Lorenzo Moretta · 2021 · Frontiers in Immunology
  39. The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease
    Maria Tsioumpekou, Daniëlle Krijgsman, Jeanette H.W. Leusen, Patricia A. Olofsen · 2023 · Cells
  40. cGAS-STING signaling in the tumor microenvironment
    Ziqi Liu, Dan Wang, Jiarong Zhang, Pingjuan Xiang, Zhaoyang Zeng, Wei Xiong, Lei Shi · 2023 · Cancer Letters
  41. T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
    Jianfeng Liu, Si‐Rui Ma, Liang Mao, Lin‐Lin Bu, Guang‐Tao Yu, Yicun Li, Cong‐Fa Huang, Wei‐Wei Deng, Ashok B. Kulkarni, Wen‐Feng Zhang et al. · 2017 · Molecular Oncology
  42. Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
    Woong-Jai Won, Jessy S. Deshane, Jianmei Wu Leavenworth, Claudia R. Oliva, Corinne E. Griguer · 2019 · Cell Stress
  43. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway
    Qi Lin, Li Ren, Mi Jian, Pingping Xu, Jun Li, Peng Zheng, Qingyang Feng, Liangliang Yang, Meilin Ji, Ye Wei et al. · 2019 · Cell Death and Disease
  44. Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery
    Leonard Angka, S. Khan, Marisa K. Kilgour, Rebecca Y. Xu, Michael A. Kennedy, Rebecca C. Auer · 2017 · International Journal of Molecular Sciences
  45. The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study
    Mireille B. Toledano, Sujit K. Mukherjee, Jessica A. Howell, David Westaby, Shahid Ahmed Khan, Diana Bilton, Nicholas J. Simmonds · 2019 · PLoS ONE
  46. Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
    Chiel van Geffen, Astrid Deißler, Markus Quante, Harald E. Renz, Dominik Hartl, Saeed Kolahian · 2021 · Frontiers in Immunology
  47. Antioxidant and Anti-Inflammatory Compounds from Edible Plants with Anti-Cancer Activity and Their Potential Use as Drugs
    Sofía Isabel Cuevas-Cianca, Cristian Romero-Castillo, José Luis Gálvez-Romero, Zaida Nelly Juárez, Luis Ricardo Hernández · 2023 · Molecules
  48. Arginine metabolism in myeloid cells in health and disease
    Eleftheria Karadima, Triantafyllos Chavakis, Vasileia Ismini Alexaki · 2025 · Seminars in Immunopathology
  49. STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
    Moreira, Dayson, Adamus, Tomasz, Zhao, Xingli, Su, Yu-Lin, Zhang, Zhuoran, White, Seok Voon, Swiderski, Piotr, Lu, Xin, DePinho, Ronald A., Pal, Sumanta K. et al. · 2018 · Clinical Cancer Research
  50. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment
    Vera M. Kho, Vera E. Mekers, Paul N. Span, Johan Bussink, Gosse J. Adema · 2021 · Cellular Immunology
  51. Immunotherapy of targeting MDSCs in tumor microenvironment
    Hongshu Sui, Shengyi Dongye, Xiaocui Liu, Xinghua Xu, Li Wang, Christopher Q. Jin, Minhua Yao, Zhaoqing Gong, Daniel Jiang, Kexin Zhang et al. · 2022 · Frontiers in Immunology
  52. Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy
    Omar Sadi Sarkar, Howard Donninger, Numan Al Rayyan, Lewis C. Chew, Bryce F. Stamp, Xiang Zhang, Aaron G. Whitt, Chi Li, Melissa Barousse Hall, Robert A. Mitchell et al. · 2023 · Science Advances
  53. Myeloid-derived suppressor cells and tumor escape from immune surveillance
    Viktor Umansky, C Blattner, Viktor Fleming, Xiaoying Hu, Christoffer Gebhardt, Peter Altevogt, Jochen Sven Utikal · 2016 · Seminars in Immunopathology
  54. The CCAAT/Enhancer-Binding Protein Family: Its Roles in MDSC Expansion and Function
    Wenxin Wang, Xueli Xia, Lingxiang Mao, Shengjun Wang · 2019 · Frontiers in Immunology
  55. Autocrine IL6-Mediated Activation of the STAT3–DNMT Axis Silences the TNFα–RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells
    Alyssa D. Smith, Chunwan Lu, Daniela Payne, Amy V. Paschall, John David Klement, Priscilla S. Redd, Mohammed L. Ibrahim, Dafeng Yang, Qimei Han, Zhuoqi Liu et al. · 2020 · Cancer Research
  56. Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease
    Aaron D. Thome, Farah Atassi, Jinghong Wang, Alireza Faridar, Weihua Zhao, Jason R. Thonhoff, David R. Beers, Eugene C. Lai, Stanley H. Appel · 2021 · npj Parkinson s Disease
  57. MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
    Christophe Vanhaver, Pierre van der Bruggen, Annika M. Bruger · 2021 · Journal of Clinical Medicine
  58. Myeloid cells in circulation and tumor microenvironment of breast cancer patients
    Salman M. Toor, Azharuddin Sajid Syed Khaja, Haytham El Salhat, Issam Faour, Jihad Kanbar, A. Quadri, Albashir Mohamed, Eyad Elkord · 2017 · Cancer Immunology Immunotherapy
  59. MDSCs in Liver Cancer: a critical tumor-promoting player and a potential therapeutic target.
    Chi Ma, Qian-Fei Zhang, T. Greten · 2021 · Cellular Immunology
  60. Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
    Saisha Abhay Nalawade, Paul W. Shafer, Pradip Bajgain, Mary Kathryn McKenna, Arushana Ali, Lauren K. Somes, Jarrett Joubert, Stephen M Gottschalk, Norihiro Watanabe, Ann Marie Leen et al. · 2021 · Journal for ImmunoTherapy of Cancer
  61. Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells
    Varikuti, Sanjay, Singh, Bhawana, Volpedo, Greta, Ahirwar, Dinesh K., Jha, Bijay K., Saljoughian, Noushin, Viana, Agostinho G., Verma, Chaitenya, Hamza, Omar, Halsey, Gregory et al. · 2020 · British Journal of Cancer
  62. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients
    Tatiana A. Karakasheva, George A. Dominguez, Ayumi Hashimoto, Eric W. Lin, Christopher Chiu, Kate Sasser, Jae Woo Lee, Gregory Lawrence Beatty, Dmitry I. Gabrilovich, Anil K. Rustgi · 2018 · JCI Insight
  63. Immunotherapy for advanced thyroid cancers — rationale, current advances and future strategies
    Jena D. French · 2020 · Nature Reviews Endocrinology
  64. Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment
    Mohammad H. Rashid, Thaiz F. Borin, Roxan Ara, Raziye Piranlioglu, Bhagelu R. Achyut, Hasan Körkaya, Yutao Liu, Ali S. Arbab · 2021 · Oncology Reports
  65. Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system
    Guanmei Wen, Leyi Yao, Yali Hao, Jinheng Wang, Jinbao Liu · 2022 · Journal of Translational Medicine
  66. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner
    Gregory Pal Takacs, Christian J. Kreiger, Defang Luo, Guimei Tian, Julia S. Garcia, Loic P. Deleyrolle, Duane A. Mitchell, Jeffrey K. Harrison · 2023 · Frontiers in Immunology
  67. IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer
    Longyong Xu, Fanglue Peng, Qin Luo, Yao Ding, Fei Yuan, Liting Zheng, Wei He, Sophie S. Zhang, Xin Fu, Jin Liu et al. · 2024 · Cell
  68. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
    Janna Heide, Agnes Julia Bilecz, Samarjit Patnaik, Maria Francesca Allega, Leonhard Donle, Kaiting Yang, Ethan A. Teich, Yan Li, Qiaoshan Lin, Ke Kong et al. · 2025 · Nature
  69. Energy metabolic pathways control the fate and function of myeloid immune cells
    Amir A. Al-Khami, Paulo C. Rodrı́guez, Augusto C. Ochoa · 2017 · Journal of Leukocyte Biology
  70. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
    Shen-Jun Yuan, Yong‐Hong Xu, Chao Wang, Hui-Chao An, Hua‐Zhen Xu, Ke Li, Naoki Komatsu, Li Zhao, Xiao Chen · 2019 · Journal of Nanobiotechnology
  71. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs
    Gregory M. Cresswell, Bingbing Wang, Erin M. Kischuk, Meaghan Maureen Broman, Rami A. Alfar, Renee E. Vickman, Dimiter Stanchev Dimitrov, Sumith A. Kularatne, Chandru P. Sundaram, Sunil Kumar Singhal et al. · 2020 · Cancer Research
  72. The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine
    Xiaojun Su, Xiuli Yan, Hui Zhang · 2025 · Molecular Cancer
  73. Staphylococcus aureus strategies to evade the host acquired immune response
    Oliver Goldmann, Eva Medina · 2017 · International Journal of Medical Microbiology
  74. Tumor Cells Induce LAMP2a Expression in Tumor-Associated Macrophage for Cancer Progression
    Ruibo Wang, Yantong Liu, Li Liu, Mei Chen, Xiuxuan Wang, H. J. Yang, Yanqiu Gong, Bi‐Sen Ding, Yuquan Wei, Xiawei Wei · 2018 · EBioMedicine
  75. Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
    Tiffany Rose Emmons, Thejaswini Giridharan, Kelly L. Singel, Anm Nazmul H. Khan, Jason Ricciuti, Kaitlyn Howard, Stephanie L. Silva-Del Toro, Ivy L. Debreceni, Cathelijn E.M. Aarts, Mieke C. Brouwer et al. · 2021 · Cancer Immunology Research
  76. Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells
    Sho Hangai, Takeshi Kawamura, Yoshitaka Kimura, Ching-Yun Chang, Sana Hibino, Daisuke Yamamoto, Yousuke Nakai, Ryosuke Tateishi, Masanobu Oshima, Hiroko Oshima et al. · 2021 · Nature Immunology
  77. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients
    Kimberly Rae Jordan, Puja Kapoor, Eric Spongberg, Richard P. Tobin, Dexiang Gao, Virginia F. Borges, Martin D. McCarter · 2017 · Cancer Immunology Immunotherapy
  78. Lnc-chop Promotes Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor and Inflammatory Environments
    Yunhuan Gao, Tiantian Wang, Yuanyuan Li, Yuan Zhang, Rongcun Yang · 2018 · The Journal of Immunology
  79. Functional alterations of myeloid cells during the course of Alzheimer’s disease
    Thome, Aaron D., Faridar, Alireza, Beers, David R., Thonhoff, Jason R., Zhao, Weihua, Wen, Shixiang, Pascual, Belen, Masdeu, Joseph C., Appel, Stanley H. · 2018 · Molecular Neurodegeneration
  80. Molecular Targeting Nanoprobes with Non-Overlap Emission in the Second Near-Infrared Window for in Vivo Two-Color Colocalization of Immune Cells
    Guang‐Tao Yu, Mengyao Luo, Hao Li, Song Chen, Biao Huang, Zhi‐Jun Sun, Ran Cui, Mingxi Zhang · 2019 · ACS Nano
  81. Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment
    Lisa Haas, Anna C. Obenauf · 2019 · Frontiers in Immunology
  82. Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity
    Laura M. Sipe, Mehdi Chaib, Ajeeth Kumar Pingili, Joseph F. Pierre, Liza Makowski · 2020 · Immunological Reviews
  83. Lnc-C/EBPβ Negatively Regulates the Suppressive Function of Myeloid-Derived Suppressor Cells
    Yunhuan Gao, Wei Sun, Wencong Shang, Yuanyuan Li, Dan Zhang, Tianze Wang, Xipeng Zhang, Shiwu Zhang, Yuan Zhang, Rongcun Yang · 2018 · Cancer Immunology Research
  84. Emerging and multifaceted role of neutrophils in lung cancer
    Christian Anthony Aloe, Hao Wang, Ross Vlahos, Louis B. Irving, Daniel Steinfort, Steven Bozinovski · 2021 · Translational Lung Cancer Research
  85. Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy
    Wen Shen, Peishang Shi, Qingyu Dong, Xiuman Zhou, Chun-Xia Chen, Xinghua Sui, Wen-Tong Tian, Xueqin Zhu, Xiaoxi Wang, Shengzhe Jin et al. · 2023 · Journal for ImmunoTherapy of Cancer
  86. Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
    Zoila Areli Lopez Bujanda, Charles G. Drake · 2017 · Journal of Leukocyte Biology
  87. A functional characteristic of cysteine‐rich protein 61: Modulation of myeloid‐derived suppressor cells in liver inflammation
    Zhang, Haiyan, Lian, Min, Zhang, Jun, Bian, Zhaolian, Tang, Ruqi, Miao, Qi, Peng, Yanshen, Fang, Jingyuan, You, Zhengrui, Invernizzi, Pietro et al. · 2018 · Hepatology
  88. PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy
    Alessandra Romano, Nunziatina Laura Parrinello, Piera La Cava, Daniele Tibullo, Cesarina Giallongo, Giuseppina Camiolo, Fabrizio Puglisi, Marina Silvia Parisi, Maria Cristina Pirosa, Enrica Antonia Martino et al. · 2018 · Expert Review of Molecular Diagnostics
  89. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis
    Dehong Yan, Jinghui Wang, Honghong Sun, Ali Zamani, Honglin Zhang, Weihong Chen, Aifa Tang, Qingguo Ruan, Xiaolu Yang, Youhai H. Chen et al. · 2019 · The Journal of Experimental Medicine
  90. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer
    Varun Sasidharan Nair, Reem Saleh, Salman M. Toor, Rowaida Ziad Taha, Ayman Ahmed, Mohamed A. Kurer, Khaled Murshed, Nehad M. Alajez, Mohamed Abu Nada, Eyad Elkord · 2020 · Clinical Epigenetics
  91. The Engagement Between MDSCs and Metastases: Partners in Crime
    Rosalinda Trovato, Stefania Canè, Varvara Petrova, Silvia Sartoris, Stefano Ugel, Francesco De Sanctis · 2020 · Frontiers in Oncology
  92. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer
    Evgenii N. Tcyganov, Shino Hanabuchi, Ayumi Hashimoto, David Graham Campbell, Gozde Kar, Timothy W.F. Slidel, Corinne Cayatte, Aimee L. Landry, Fernanda Pilataxi, Susana Hayes et al. · 2021 · Journal of Clinical Investigation
  93. Autoimmunity and Cancer—Two Sides of the Same Coin
    Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, Ines Papak, Aleksandra Markiewicz, Katarzyna Dziubek, Małgorzata Kurkowiak, Sachin Kote, Karolina Kaźmierczak-Siedlecka, Karol Połom et al. · 2022 · Frontiers in Immunology
  94. Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy
    Suzanne Ostrand‐Rosenberg, Lucas A. Horn, Nicholas G. Ciavattone · 2019 · Frontiers in Oncology
  95. Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer
    Wesolowski, Robert, Duggan, Megan C., Stiff, Andrew, Markowitz, Joseph, Trikha, Prashant, Levine, Kala M., Schoenfield, Lynn, Abdel-Rasoul, Mahmoud, Layman, Rachel, Ramaswamy, Bhuvaneswari et al. · 2017 · Cancer Immunology, Immunotherapy
  96. Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
    Salman M. Toor, Azharuddin Sajid Syed Khaja, Haytham El Salhat, Omar Bekdache, Jihad Kanbar, Mohammed Jaloudi, Eyad Elkord · 2016 · Frontiers in Immunology
  97. Regulation of Immunity in Breast Cancer
    Chidalu A. Edechi, Nnamdi M. Ikeogu, Jude Ezeh Uzonna, Yvonne Myal · 2019 · Cancers
  98. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
    N Karin · 2020 · Frontiers in Immunology
  99. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy
    Man Liu, Jingying Zhou, Zhiwei Chen, Alfred S.L. Cheng · 2016 · The Journal of Pathology
  100. Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
    Melissa Mavers, Kristina Maas‐Bauer, Robert S. Negrin · 2017 · Frontiers in Immunology